Fredun Pharma

74
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
1,685.55
-8.2 (-0.48%)
BSENSE

Mar 30

BSE+NSE Vol: 6.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023

Compare Profit and Loss Results of Fredun Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
542.00
-194.00
-35.79%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
542.00
-194.00
-35.79%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-20.00
-2.00
-10.00%
Raw Materials Consumed
282.00
307.00
-25.00
-8.14%
Power & Fuel Cost
4.00
22.00
-18.00
-81.82%
Employee Cost
12.00
57.00
-45.00
-78.95%
Operating Expenses
10.00
63.00
-53.00
-84.13%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
6.00
-1.00
-16.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
6.00
-5.00
-83.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
460.00
-150.00
-32.61%
Operating Profit (PBDIT) excl Other Income
37.00
82.00
-45.00
-54.88%
Other Income
0.00
19.00
-19.00
-100.00%
Operating Profit (PBDIT)
38.00
101.00
-63.00
-62.38%
Interest
13.00
27.00
-14.00
-51.85%
Profit before Depriciation and Tax
25.00
73.00
-48.00
-65.75%
Depreciation
3.00
27.00
-24.00
-88.89%
Profit Before Taxation & Exceptional Items
21.00
46.00
-25.00
-54.35%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
46.00
-25.00
-54.35%
Provision for Tax
5.00
3.00
2.00
66.67%
Profit After Tax
15.00
42.00
-27.00
-64.29%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
267.00
-239.00
-89.51%
Profit Available for appropriations
44.00
310.00
-266.00
-85.81%
Appropriations
44.00
310.00
-266.00
-85.81%
Equity Dividend (%)
7%
20%
-13.00
Earnings Per Share
33.66
13.29
20.37
153.27%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023